Unknown

Dataset Information

Practice-based evidence: profiling the safety of cilostazol by text-mining of clinical notes.


ABSTRACT:

Background

Peripheral arterial disease (PAD) is a growing problem with few available therapies. Cilostazol is the only FDA-approved medication with a class I indication for intermittent claudication, but carries a black box warning due to concerns for increased cardiovascular mortality. To assess the validity of this black box warning, we employed a novel text-analytics pipeline to quantify the adverse events associated with Cilostazol use in a clinical setting, including patients with congestive heart failure (CHF).

Methods and results

We analyzed the electronic medical records of 1.8 million subjects from the Stanford clinical data warehouse spanning 18 years using a novel text-mining/statistical analytics pipeline. We identified 232 PAD patients taking Cilostazol and crea

SUBMITTER: Leeper NJ 

PROVIDER: S-EPMC3662653 | biostudies-literature | 2013

REPOSITORIES: biostudies-literature